Trial reportClinical & experimental metastasis2012
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.
Trial report in Clinical & experimental metastasis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.
- Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.The Cochrane database of systematic reviews · 2015Pooled it
- The Role of Sentinel Node Biopsy in the Era of Adjuvant Therapy for Melanoma.Dermatology practical & conceptual · 2024Review
- The Evolution of the Sentinel Node Biopsy in Melanoma.Life (Basel, Switzerland) · 2023Review
- Article
- A population-based study of administrative data linkage to measure melanoma surgical and pathology quality.PloS one · 2022Article
- Application of an indocyanine green surgical fluorescence imaging system in sentinel lymph node biopsy of acral malignant melanoma.Annals of translational medicine · 2021Article
- Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients.Cancers · 2020Article
- Laparoscopically assisted ilio-inguinal lymph node dissection versus inguinal lymph node dissection in melanoma.Melanoma management · 2020Article
- Detection of Occult Metastases in Patients with T1 and T2 Stage Lower Lip Squamous Cell Carcinomas after Positive Lymphoscintigraphy.Diagnostics (Basel, Switzerland) · 2020Article
- Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.JAMA dermatology · 2019Article
- Evaluation of Chest Radiographs and Laboratory Testing during Melanoma Staging Procedures.The American surgeon · 2019Article
- Metastatic melanoma vs lymphoma. Using a sentinel lymph node biopsy a diagnostic tool.Journal of surgical case reports · 2019Article
- Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis.Cancer discovery · 2019Article
- Cancer initiation and progression within the cancer microenvironment.Clinical & experimental metastasis · 2018Review
- Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions.Clinical & experimental metastasis · 2018Review
- Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.The British journal of surgery · 2018Article
- Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.Journal of surgical oncology · 2017Article
- The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy.Lasers in medical science · 2017Review
- Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.Annals of surgical oncology · 2017Article
- Lymph node retrieval rates in melanoma: a quality assessment parameter.Current oncology (Toronto, Ont.) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.